Skip to main content

Animations

MJFF Publications

5251 - 5260 of 9038 Results
Title
Year
  • Year
  • 2014
  • 2010
  • 2010
  • 2012
  • 2013
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awu179
    Citation Count: 200
  • Summary Details
    OPEN
    Title: Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2010.05.009
    Citation Count: 218
  • Summary Details
    OPEN
    Title: Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1042/bj20100784
    Citation Count: 388
  • Summary Details
    OPEN
    Title: Pantothenate kinase‐associated neurodegeneration is not a synucleinopathy
    Journal Name: Neuropathology and Applied Neurobiology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: unspecified-oa, unspecified-oa
    DOI - Digital Object Identifier: 10.1111/j.1365-2990.2012.01269.x
    Citation Count: 55
  • Summary Details
    OPEN
    Title: The novel MAPT mutation K298E: mechanisms of mutant tau toxicity, brain pathology and tau expression in induced fibroblast-derived neurons
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-013-1219-1
    Citation Count: 35
  • Summary Details
    OPEN
    Title: The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.cell.2022.05.008
    Citation Count: 168
  • Summary Details
    OPEN
    Title: Dopaminergic Positron Emission Tomography Imaging in the Alpha‐Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29051
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.molcel.2022.06.005
    Citation Count: 74
  • Summary Details
    OPEN
    Title: Generation of realistic synthetic data using Multimodal Neural Ordinary Differential Equations
    Journal Name: npj Digital Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41746-022-00666-x
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Estrogen-related receptor gamma regulates mitochondrial and synaptic genes and modulates vulnerability to synucleinopathy
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00369-w
    Citation Count: 35
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.